A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective. [electronic resource]
Producer: 20170109Description: 287-304 p. digitalISSN:- 1618-7601
- Cost-Benefit Analysis
- Cryotherapy -- economics
- Diclofenac -- economics
- Diterpenes -- administration & dosage
- Dose-Response Relationship, Drug
- Fluorouracil -- economics
- Humans
- Keratolytic Agents -- administration & dosage
- Keratosis, Actinic -- drug therapy
- Models, Econometric
- Quality-Adjusted Life Years
- Recurrence
- Salicylic Acid -- economics
- Scotland
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.